 |
Robert Peter Gale | |
|---|---|
 Gale in 1986 | |
| Born | October 11, 1945 |
| Alma mater | Hobart and William Smith Colleges State University of New York University of California |
| Occupation(s) | Physician, medical researcher |
Robert Peter Gale (born October 11, 1945) is an American physician and medical researcher. He is known for research in leukemia and other bone marrow disorders (such as aplastic anemia). [1]
Gale received his A.B. degree with honors in biology and chemistry from Hobart College in 1966 and his M.D. degree from the State University of New York at Buffalo in 1970 (with Evan Caukins, Robin Bannerman and John Edwards). His postgraduate medical training (internal medicine, hematology and oncology) was at the University of California, Los Angeles (UCLA) from 1970 to 1973. In 1976 he received a Ph.D. in microbiology and immunology from the University of California at Los Angeles (UCLA) following doctoral work focusing on cancer immunology (with John Fahey). His postdoctoral studies at UCLA were funded by the U.S. National Institutes of Health (NIH) and the Leukemia Society of America, where he was the Bogart Fellow and Scholar.
From 1973 to 1993, Gale was on the faculty of the UCLA School of Medicine in the Department of Medicine, Division of Hematology & Oncology, where he focused on the molecular biology, immunology and treatment of leukemia. He also developed the bone marrow transplant program supported by the NIH. At UCLA, he was active in the Department of Psychology, where he and his colleagues studied interactions among stress, immunity and cancer.
From 1980 to 1997, Gale was Chairman of the Scientific Advisory Committee of the Center for International Blood and Marrow Transplant Research (CIBMTR), an organization of more than 400 transplant centers in over 60 countries worldwide working together to analyze and advance knowledge about blood cell and bone marrow transplants. From 1989 to 2003 Gale chaired the Scientific Advisory Board of the Center for Advanced Studies in Leukemia, a charity funding innovation leukemia research.
From 1986 to 1993, Gale was President of the Armand Hammer Center for Advanced Studies in Nuclear Energy and Health, a foundation supporting research on medical aspects of nuclear issues. From 1985 to 1990 he was the Wald Scholar in Biomedical Communications at UCLA. During this time he volunteered his expertise in bone marrow transplants to the USSR, for the victims of radiation poisoning incurred during the Chernobyl nuclear disaster. He aided Dr. Alexander Buranov and Dr. Angelina Guskova at Moscow's Hospital #6, a state hospital specializing in treating radiation sickness.
From 1993 to 1999, Gale was Senior Physician and Corporate Director of Bone Marrow and Blood Cell Transplantation at Salick Health Care (SHC), Inc. in Los Angeles (now Aptium Oncology), a subsidiary of AstraZeneca. Gale was also responsible for developing cancer treatment guidelines (in collaboration with colleagues at RAND and Value Health Sciences) and for studying medical aspects of managed cancer care.
From 2000 to 2004 he was Senior Vice President for Medical Affairs at Antigenics Inc., in New York where he was responsible for design, implementation and analysis of clinical trials of cancer vaccines. He was also Senior Medical Consultant to Oxford Health Plans in areas of advanced medical technologies. From 2004 to 2007, Gale was Senior Vice President of Research for ZIOPHARM Oncology in Boston, Massachusetts and New York, New York, which he helped co-found. His focus was on developing and testing new cancer therapies. His activities included development and execution of clinical trials in blood and bone marrow cancers, transplantation and immune disorders. Since 2005 Gale has been a Visiting Professor of Haematology in the Centre for Haematology, Department of Immunology and Inflammation, Imperial College, London assigned to Hammersmith Hospital. He is an editor, co-editor and reviewer of many scientific journals in hematology, oncology, immunology, transplantation and internal medicine.
Gale is regarded as a world expert on the medical response to nuclear and radiation accidents and has participated in rescue efforts at Chernobyl, Goiânia, Tokaimura, Fukushima and others. In 2012, after extensive analysis of the Japanese data, he said that "the increased risk of cancer incidence [from the Fukushima Daiichi nuclear disaster] would be only 0.002 percent for a member of the Japanese public". [2]
Gale has contributed to basic science and clinical research in bone marrow transplantation where he made contributions to understanding the immune-mediated anti-leukemia effects of transplants (graft-versus-leukemia). He has also advanced understanding of other complex immune effects of transplants in humans, like graft-versus-host disease and post-transplant immune deficiency. He has worked on alternate sources of hematopoietic stem cells including fetal liver transplants.
In 1986, he was asked by the government of the Soviet Union to coordinate medical relief efforts for victims of the Chernobyl disaster. [3] In 1987, he was asked by the government of Brazil to coordinate medical relief efforts for the Goiânia accident. In 1988, he was part of the U.S. medical emergency team sent in the aftermath of the earthquake in Armenia. In 1999 he was asked by the government of Japan to help treat victims of the Tokaimura nuclear accident. In 2011 Gale was called to Japan to deal with medical consequences of the Fukushima nuclear power station accident. He met with members of the Prime Minister's office on several occasions and has addressed the Diet on three occasions. Gale has also been a neutral war observer for the governments of Croatia and Armenia and a medical consultant to the government of Tatarstan. Gale has received several awards for his humanitarian activities including the Olender Peace Prize, City of Los Angeles Humanitarian Award and Myasthenia Gravis Foundation Humanitarian Award.
Gale has published over 1150 scientific articles and more than 20 books,[ citation needed ] mostly on leukemia (biology and treatment), transplantation (biology, immunology and treatment), cancer immunology, and radiation health effects and accident response. He has written on medical topics, nuclear energy and weapons and politics of US-Soviet relations in articles for The New York Times , Los Angeles Times , The Washington Post , USA Today and The Wall Street Journal .
In addition to his academic publications, Gale has written popular books on the Chernobyl accident and US nuclear energy policy. He has written parts of screenplays for, and appeared in, several movies including Chernobyl: The Final Warning (with Jon Voight), [4] Fat Man and Little Boy (with Paul Newman), and City of Joy (with Patrick Swazye). His latest book, Radiation: What it is, What you need to know, with Eric Lax, was published in February 2013. [5]
Awards for his scientific achievements include the Presidential Award, New York Academy of Sciences, Scientist of Distinction Award, Weizmann Institute of Science, Distinguished Alumni Award from Hobart College and Intra-Science Research Foundation Award. He holds honorary degrees including D.Sc. from Albany Medical College, D.Sc from the State University of New York Buffalo, L.H.D. from Hobart College and D.P.S from MacMurray College. In 2018 he was accepted as a fellow in the Royal College of Physicians. He received an Emmy award for his work on a 60 Minutes special report about Chernobyl.
Gale lives in Los Angeles, New York City and Big Sky, MT with his wife Laura. [6]
Leukemia is a group of blood cancers that usually begin in the bone marrow and result in high numbers of abnormal blood cells. These blood cells are not fully developed and are called blasts or leukemia cells. Symptoms may include bleeding and bruising, bone pain, fatigue, fever, and an increased risk of infections. These symptoms occur due to a lack of normal blood cells. Diagnosis is typically made by blood tests or bone marrow biopsy.
Bone marrow is a semi-solid tissue found within the spongy portions of bones. In birds and mammals, bone marrow is the primary site of new blood cell production. It is composed of hematopoietic cells, marrow adipose tissue, and supportive stromal cells. In adult humans, bone marrow is primarily located in the ribs, vertebrae, sternum, and bones of the pelvis. Bone marrow comprises approximately 5% of total body mass in healthy adult humans, such that a man weighing 73 kg (161 lbs) will have around 3.7 kg (8 lbs) of bone marrow.
Edward Donnall "Don" Thomas was an American physician, professor emeritus at the University of Washington, and director emeritus of the clinical research division at the Fred Hutchinson Cancer Research Center. In 1990 he shared the Nobel Prize in Physiology or Medicine with Joseph E. Murray for the development of cell and organ transplantation. Thomas and his wife and research partner Dottie Thomas developed bone marrow transplantation as a treatment for leukemia.
Dartmouth Cancer Center (DCC) is a comprehensive cancer research center as designated by the National Cancer Institute. It is located at Dartmouth College and the Geisel School of Medicine in Hanover, New Hampshire. Its administrative offices are located within the Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire.
Acute myeloid leukemia (AML) is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal cells that build up in the bone marrow and blood and interfere with normal blood cell production. Symptoms may include feeling tired, shortness of breath, easy bruising and bleeding, and increased risk of infection. Occasionally, spread may occur to the brain, skin, or gums. As an acute leukemia, AML progresses rapidly, and is typically fatal within weeks or months if left untreated.
The University of California, Los Angeles School of Medicine, also known as the David Geffen School of Medicine at UCLA (DGSOM), is an accredited medical school located in Los Angeles, California, United States. Founded in 1951, it is the second medical school in the University of California system, after the UCSF School of Medicine. The school was renamed in 2001 in honor of media mogul David Geffen who donated $200 million in unrestricted funds.
Stephen Gould Emerson is an American academic who was the 13th president of Haverford College from July 1, 2007, to August 10, 2011. In February 2012, he was appointed Director of the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center, and he will also hold the Clyde ’56 and Helen Wu Professorship in Immunology at the Columbia University Vagelos College of Physicians and Surgeons.
Peripheral blood stem cell transplantation (PBSCT), also called "Peripheral stem cell support", is a method of replacing blood-forming stem cells. Stem cells can be destroyed through cancer treatments such as chemotherapy or radiation, as well as any blood-related diseases, such as leukemia, lymphoma, neuroblastoma and multiple myeloma. PBSCT is now a much more common procedure than its bone marrow harvest equivalent due to the ease and less invasive nature of the procedure. Studies suggest that PBSCT has a better outcome in terms of the number of hematopoietic stem cell yield.
Allen Charles Edward Eaves is the co-founding Director of the Terry Fox Laboratory for Hematology/Oncology Research, which over a 25-year period (1981–2006) he grew into an internationally recognized centre for the study of leukemia and stem cell research. His own research on chronic myelogenous leukemia (CML) has led the way to a new understanding of the disease. As Head of Hematology at the British Columbia Cancer Agency and the University of British Columbia for 18 years (1985–2003) he engineered the building of one of the first and largest bone marrow transplant programs in Canada. In recognition of his research accomplishments and leadership in moving basic science discoveries in stem cell biology into the clinic, he was elected President of the International Society of Cellular Therapy (1995–1997), Treasurer of the Foundation for the Accreditation of Cellular Therapy (1995–2002) and President of the American Society of Blood and Marrow Transplantation (1999–2000). In 2003 he was awarded the prestigious R. M. Taylor Medal by the Canadian Cancer Society and the National Cancer Institute of Canada.
Georges Mathé was a French oncologist and immunologist. In November 1958, he performed the first successful allogeneic bone marrow transplant ever performed on unrelated human beings.
High-dose chemotherapy and bone marrow transplant (HDC/BMT), also high-dose chemotherapy with autologous bone marrow transplant, was an ineffective treatment regimen for metastatic breast cancer, and later high-risk breast cancer, that was considered promising during the 1980s and 1990s. With an overall idea that more is better, this process involved taking cells from the person's bone marrow to store in a lab, then to give such high doses of chemotherapy drugs that the remaining bone marrow was destroyed, and then to inject the cells taken earlier back into the body as replacement. It was ultimately determined to be no more effective than normal treatment, and to have significantly higher side effects, including treatment-related death.
King Fahad Specialist Hospital-Dammam (KFSHD) is a district general hospital in the Eastern region of Saudi Arabia.
Roland Mertelsmann is a German hematologist and oncologist. He was a professor at the Freiburg University Medical Center, Department of Internal Medicine I (Oncology/Hematology). Mertelsmann is known for his scientific works in the fields of hematology, oncology, gene therapy and stem cell transplantation.
Guo Mei is a hematologist and associate director of 307th Hospital of Chinese People’s Liberation Army and deputy director of Radiation Research Institute.
Ashok K. Vaid is an Indian medical oncologist, known for his pioneering efforts in bone marrow transplantation in India. He is credited with the performance of the first 25 bone marrow transplantations in the private sector in North India. He heads the Cancer Institute- Division of Medical Oncology and Haemotology at Medanta The Medicity.
Olga Aleinikova — is a pediatric-oncohematologist, PhD, Doctor of Medical Science (1999), Professor (2003), Corresponding Member of the National Academy of Sciences of Belarus, Director of State Institution "Belarusian Research Center for Pediatric Oncology, Hematology and Immunology".
Rajiv Gandhi Cancer Institute and Research Centre (RGCIRC) is a non-profit medical facility and research institute based in Delhi, India specialising in cancer treatment and research. It is one of the largest medical centers for cancer treatment in Asia. RGCIRC is a project of Indraprastha Cancer Society and Research Centre, a not-for-profit public society. The institute was founded in 1996.
Shimon Slavin is an Israeli professor of medicine. Slavin pioneered the use of immunotherapy mediated by allogeneic donor lymphocytes and innovative methods for stem cell transplantation for the cure of hematological malignancies and solid tumors, and using hematopoietic stem cells for induction of transplantation tolerance to bone marrow and donor allografts.
Martin Körbling is a German-American internist and hematologist, university professor, medical researcher and pioneer of blood stem cell transplantation.
Philip Greenberg is a professor of medicine, oncology, and immunology at the University of Washington and head of program in immunology at the Fred Hutchinson Cancer Research Center. His research is centered around T cell biology and therapeutic cell therapies. He is a co-founder of Juno Therapeutics.
| International | |
|---|---|
| National | |
| Academics | |
| Other | |
